Page 97 - MONOGRAFIA 25, de Esclerosis multiple

MICROBIOTA Y ESCLEROSIS MÚLTIPLE
03
28. Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018 Jun;83(6):1147-61. doi: 10.1002/ana.25244
29. Castillo-Álvarez F, Marzo-Sola ME. Role of intestinal microbiota in the development of multiple sclerosis. Neurologia. 2017 Apr;32(3):175-84. Disponible en: http://www.ncbi.nlm.nih.gov/ pubmed/26383059.
30. Libbey JE, Sánchez JM, Doty DJ, Sim JT, Cusick MF, Cox JE, et al. Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model. Benef Microbes. 2018 Jan 30;1-20. Disponible en: http://www.wageningenacademic.com/ doi/10.3920/BM2017.0116.
31. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome. 2013 Jan 9;1(1):3. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24467987.
97